Quality of life and symptom assessment in randomized clinical trials of bladder cancer: A systematic review Journal Article


Authors: Feuerstein, M. A.; Jacobs, M.; Piciocchi, A.; Bochner, B.; Pusic, A.; Fayers, P.; Blazeby, J.; Efficace, F.
Article Title: Quality of life and symptom assessment in randomized clinical trials of bladder cancer: A systematic review
Abstract: Objectives: Patient-reported outcomes (PRO) help patients, caretakers, clinicians, and policy makers make informed decisions regarding treatment effectiveness. Our objective was to assess the quality of PRO reporting and methodological strengths and weaknesses in randomized controlled trials (RCT) in bladder cancer. Methods: A systematic literature search of bladder cancer RCT published between January 2004 and March 2014 was performed. Relevant studies were evaluated using a predetermined extraction form that included trial demographics, clinical and PRO characteristics, and standards of PRO reporting based on recommendations of the International Society for Quality of Life Research. Results: In total, 9 RCTs enrolling 1,237 patients were evaluated. All studies were in patients with nonmetastatic disease. In 5 RCTs, a PRO was the primary end point. Most RCTs did not report the mode of administration of the PRO instrument or the methods of collecting data. No RCT addressed the statistical approaches for missing data. Conclusions: We found that few RCTs in bladder cancer report PRO as an outcome. Efforts to expand PRO reporting to more RCTs and improve the quality of PRO reporting according to recognized standards are necessary for facilitating clinical decision making. © 2015 Elsevier Inc.
Keywords: cancer patient; demography; quality of life; bladder cancer; standard; systematic review; clinical decision making; patient-reported outcomes; clinical trials; randomized controlled trial (topic); human; priority journal; article; symptom assessment
Journal Title: Urologic Oncology: Seminars and Original Investigations
Volume: 33
Issue: 7
ISSN: 1078-1439
Publisher: Elsevier Inc.  
Date Published: 2015-07-01
Start Page: 331.e17
End Page: 331.e23
Language: English
DOI: 10.1016/j.urolonc.2015.04.002
PROVIDER: scopus
PMCID: PMC4466160
PUBMED: 25956189
DOI/URL:
Notes: Export Date: 2 July 2015 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Andrea Pusic
    300 Pusic
  2. Bernard Bochner
    468 Bochner